Search results
Results From The WOW.Com Content Network
Fibroids are benign (non-cancerous) muscle tumors of the uterus that can cause heavy menstrual bleeding, pain, bowel or bladder problems and infertility. [2] Some women may not experience any symptoms, but many do, including heavy bleeding with periods. [2] Fibroids can occur at any age but are most common in women 35 to 49 years of age. [2]
Elagolix is used in the treatment of moderate to severe pain associated with endometriosis in premenopausal women. [1] Endometriosis is a condition in which the endometrium, the inner lining of the uterus, grows outside of the uterus into surrounding tissues and causes symptoms such as pelvic pain and infertility. [13]
The typical adult gains an average of 1 to 2 pounds per year, which over time, can contribute to obesity. This weight gain can be driven by physical inactivity, stress, poor sleep and poor food ...
From antipsychotics to SSRIs, here's how different types of antidepressants can affect your weight. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...
“There are many medications that may cause weight gain,” says W. Scott Butsch, M.D., director of obesity medicine in the Bariatric and Metabolic Institute at the Cleveland Clinic.
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...
“Clinicians and patients can use this information, among other factors, to help decide on the right choice for them,” he added. Greatest risk of at least 5% weight gain at six months of use ...
[60] [61] The thiazolidinediones, on the other hand, may cause weight gain, but decrease central obesity. [62] Diabetics also achieve modest weight loss with fluoxetine and orlistat over 12–57 weeks. [63] Rimonabant (Acomplia), another drug, had been withdrawn from the market. It worked via a specific blockade of the endocannabinoid system.